Registry for an OncoSil implant in locally advanced pancreatic cancer
Part of Cancer, Digestive system, Hormones & metabolism clinical trials.
This observational registry tracks patients with locally advanced, unresectable pancreatic cancer who receive an OncoSil implant and then start standard chemotherapy. It may help doctors understand how the implant is used in real life and how patients do over time.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have confirmed pancreatic cancer that cannot be removed with surgery (locally advanced and unresectable).
- You will get an OncoSil implant at a hospital/clinic that is allowed to do this trial.
- You are at least 18 years old and can sign the registry consent form.
- Your pancreatic tumor is smaller than 7 cm at its longest point and under 110 cc in volume.
- There is no spread to distant organs on your baseline CT scan.
- You can start gemcitabine-based chemotherapy after signing up (per usual care schedule).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study follows patients with pancreatic cancer who receive the OncoSil implant. It collects real-world data to learn more about how well the treatment works outside of a formal clinical trial.
This trial tests a new treatment where doctors use imaging to guide radioactive particles directly into locally advanced pancreatic cancer tumors that haven't spread. The goal is to shrink or control the cancer with radiation delivered right to the tumor.
This registry collects information about people with advanced pancreatic cancer who are receiving first-line palliative treatment. It helps doctors understand which treatment choices are used and how people do over time.
This is a research registry that collects information from adults with suspected or diagnosed pancreatic cancer. It may help doctors better understand the disease and improve care over time.
This is a research registry that collects information from adults with pancreatic cancer who are treated with an ablation procedure called irreversible electroporation (IRE). It may help doctors better understand which patients benefit from this approach and how the treatment is used in real life.
This trial tests a new treatment for people with advanced pancreatic cancer that has spread and is not removable by surgery, after standard treatments like chemotherapy no longer work. The goal is to see if this experimental therapy can help shrink tumors or slow the disease.
Hear when a new Neoplasms by Site trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.